U.S. market Closed. Opens in 17 hours 19 minutes

STOK | Stoke Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue8.78M12.40MN/AN/AN/AN/AN/A
Cost of Revenue4.73M3.54M2.23M1.93M450.00KN/AN/A
Gross Profit4.05M8.87M-2.23M-1.93M-450.00KN/AN/A
Operating Expenses118.82M116.76M86.06M53.04M35.68M12.78M5.55M
Selling, General & Admin39.06M38.92M31.90M20.85M11.91M4.41M1.96M
Research & Development79.76M77.84M54.17M32.20M23.76M8.37M3.60M
Other Operating Expenses166.00K167.00K140.00K57.00K2.00K-10.00KN/A
Operating Income-114.77M-104.36M-86.06M-53.04M-35.68M-12.78M-5.55M
Other Expenses / Income10.07M3.29M260.00K801.00K3.35M-10.00K-4.00K
Before Tax Income-104.70M-101.07M-85.81M-52.24M-32.33M-12.52M-5.56M
Income Tax Expenses4.56M-7.96M-1.09M-1.63M-3.80M260.00KN/A
Net Income-104.70M-93.11M-84.71M-50.61M-28.52M-12.52M-5.56M
Interest Expenses9.91M3.12M120.00KN/AN/AN/AN/A
Basic Shares Outstanding43.99M38.90M36.74M33.49M17.97M23.51M12.79M
Diluted Shares Outstanding43.99M38.90M36.74M33.49M17.97M23.51M12.79M
EBITDA-110.04M-104.36M-86.06M-53.04M-35.68M-12.57M-5.45M
EBITDA Margin-1,253.35%-841.24%0.00%0.00%0.00%0.00%0.00%
EBIT-90.23M-97.94M-85.69M-52.24M-32.33M-12.26M-5.56M
EBIT Margin-1,027.68%-789.56%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙